He made a conceptual leap in immunotherapy by creating a hybrid T-cell, known as CAR-T, that was genetically modified to ...

Baystreet.ca News Commentary – More and more young women are getting diagnosed with cancer than ever before, causing many to sound the alarm about reduced funding for prevention ...

USA News Group News Commentary – Cancer diagnoses are climbing fastest among younger women, sparking alarm that looming cuts ...

In the battle against aggressive breast cancer, a once-elusive target is now within reach—thanks to a breakthrough from a ...

During a live event, Bruna Pellini, MD, discussed IO monotherapy as a first-line option for non–small cell lung cancer with ...

Up to 40% of ER-positive breast cancers have a PIK3CA mutation and are associated with poor prognosis; this approval helps address an urgent unmet need2-4 Itovebi is the first PI3K-targeted therapy to ...

Colon cancer remains a major global health concern, ranking third among the most diagnosed cancers and leading causes of ...

Relative to existing gene signatures, the STRESS signature better predicted not only whether cells would later develop into ...

A stage-four cancer diagnosis once sounded like the end of the road – after all, there is no stage five. When Joe Biden’s ...

The Cancer Immunotherapy market, valued at USD 220.94 billion in 2024, is expected to register robust revenue CAGR of 13.6%.

FDA designates T-DXd plus pertuzumab as breakthrough therapy for HER2-positive metastatic breast cancer, promising improved ...

In this valuable study, the authors provide a simple yet elegant approach to identifying therapeutic targets that synergize to prevent therapeutic resistance in ovarian cancer using cell lines, ...